Adjuvant Hepatic Arterial Infusional Chemotherapy with 5-Fluorouracil and Cisplatin after Curative Resection of Hepatocellular Carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Do Young | - |
dc.contributor.author | Ahn, Sang Hoon | - |
dc.contributor.author | Kim, Seung Up | - |
dc.contributor.author | Choi, Sae Byeol | - |
dc.contributor.author | Lee, Kwang-Hun | - |
dc.contributor.author | Park, Mi Sook | - |
dc.contributor.author | Park, Jun Yong | - |
dc.contributor.author | Lee, Do Yun | - |
dc.contributor.author | Han, Kwang-Hyub | - |
dc.contributor.author | Kim, Kyung Sik | - |
dc.date.accessioned | 2021-09-07T21:54:03Z | - |
dc.date.available | 2021-09-07T21:54:03Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 0030-2414 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/115032 | - |
dc.description.abstract | Objectives: We investigated whether adjuvant hepatic arterial infusional chemotherapy (HAIC) with 5-fluorouracil (5FU) and cisplatin reduces the recurrence of hepatocellular carcinoma (HCC) after curative resection. Methods: Between January 2006 and December 2008, 31 HCC patients received four cycles of adjuvant HAIC with 5-FU and cisplatin via port system after curative resection. During the same period, 62 patients, who did not take any adjuvant therapy, were selected as controls. Results: Tumor characteristics, such as distribution of TNM stage, pathologic differentiation, portal vein invasion, or microscopic invasion did not differ between control and adjuvant groups. During follow-up, recurrence developed in 11 adjuvant (35.5%) and 24 control patients (38.7%; p = 0.823). Tumor progression after recurrence was the cause of death in 2 adjuvant (28.6%) and 7 control patients (38.8%; p = 0.912). The 2-year recurrence rate was 9.1% in the adjuvant group and 4.2% in the control group, with the median recurrence-free survival time being 10.5 and 7.5 months, respectively (p = 0.324). The 3-year cumulative survival rate was 73.3% in the adjuvant group and 68.3% in the control group (p = 0.355). Conclusion: Adjuvant HAIC with 5-FU and cisplatin did not offer any beneficial effect on the recurrence after curative resection of HCC. Copyright (C) 2011 S. Karger AG, Basel | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KARGER | - |
dc.subject | RISK-FACTORS | - |
dc.subject | PORTAL-VEIN | - |
dc.subject | DOSE 5-FLUOROURACIL | - |
dc.subject | TUMOR THROMBOSIS | - |
dc.subject | RECURRENCE | - |
dc.subject | PROGNOSIS | - |
dc.subject | SURVIVAL | - |
dc.subject | LIPIODOL | - |
dc.subject | TRIAL | - |
dc.subject | HCC | - |
dc.title | Adjuvant Hepatic Arterial Infusional Chemotherapy with 5-Fluorouracil and Cisplatin after Curative Resection of Hepatocellular Carcinoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Sae Byeol | - |
dc.identifier.doi | 10.1159/000333827 | - |
dc.identifier.scopusid | 2-s2.0-84255170904 | - |
dc.identifier.wosid | 000298736400008 | - |
dc.identifier.bibliographicCitation | ONCOLOGY, v.81, no.3-4, pp.184 - 191 | - |
dc.relation.isPartOf | ONCOLOGY | - |
dc.citation.title | ONCOLOGY | - |
dc.citation.volume | 81 | - |
dc.citation.number | 3-4 | - |
dc.citation.startPage | 184 | - |
dc.citation.endPage | 191 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | PORTAL-VEIN | - |
dc.subject.keywordPlus | DOSE 5-FLUOROURACIL | - |
dc.subject.keywordPlus | TUMOR THROMBOSIS | - |
dc.subject.keywordPlus | RECURRENCE | - |
dc.subject.keywordPlus | PROGNOSIS | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | LIPIODOL | - |
dc.subject.keywordPlus | TRIAL | - |
dc.subject.keywordPlus | HCC | - |
dc.subject.keywordAuthor | Hepatocellular carcinoma | - |
dc.subject.keywordAuthor | Adjuvant therapy | - |
dc.subject.keywordAuthor | Hepatic arterial infusional chemotherapy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.